Micromedic Technologies Ltd diagnostics interface makes it easy to digest most current publicly released information about Micromedic Technologies as well as get updates on important government artifacts including earning estimates, SEC corporate filings and announcements. This module also helps to analysis Micromedic Technologies price relationship with some important fundamental indicators such as market cap and management efficiency.
Micromedic Technologies Note
The company recorded loss per share of 0.3. Micromedic Technologies Ltd last dividend was issued on 2003-06-09. This company had a split on 2015-11-08. Micromedic Technologies Ltd. engages in the development and commercialization of in vitro cancer diagnostic products and solutions in Israel. In addition, it offers gene expression, and biomarker and histochemical assays for early cancer detection and personalized medicine. Micromedic Technologies operates under Diagnostics Research classification in Israel and is traded on Tel Aviv Stock Exchange. To find out more about MICROMEDIC contact Guy Lerner at 972 73 2753450 or learn more at http://www.m-medic.com.
Micromedic Technologies Alerts
Micromedic Technologies generates negative expected return over the last 30 days
Micromedic Technologies has high likelihood to experience some financial distress in the next 2 years
The company has S1.87 Million in debt which may indicate that it relies heavily on debt financing
The company reported revenue of 518K. Net Loss for the year was (6.35M) with profit before overhead, payroll, taxes, and interest of 271K.
MICROMEDIC has accumulated about 2.66M in cash with (5.56M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.11.
The company currently falls under 'Micro-Cap' category with current market capitalization of 12.57M.
Micromedic Technologies Ltd has return on total asset (ROA) of (34.13) % which means that it has lost $34.13 on every $100 spent on asset. This is way below average. Similarly, it shows return on equity (ROE) of (248.32) % meaning that it generated substantial loss on money invested by shareholders.
null. The output start index for this execution was zero with a total number of output elements of zero. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Micromedic Technologies middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Micromedic Technologies. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target. View also all equity analysis or get more info about bollinger bands overlap studies indicator.
Micromedic Technologies Technical and Predictive Indicators